Fixed Dose NESP Study in Subjects With CRI

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

February 28, 2002

Study Completion Date

February 28, 2002

Conditions
Pre-Dialysis
Interventions
DRUG

darbepoetin alfa

10 mcg NESP administered SC every other week 15 mcg NESP administered SC every other week 20 mcg NESP administered SC every other week 30 mcg NESP administered SC every other week 40 mcg NESP administered SC every other week 50 mcg NESP administered SC every other week 60 mcg NESP administered SC every other week 80 mcg NESP administered SC every other week 100 mcg NESP administered SC every other week

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY